Pharmatest to participate in the ASBMR 2023 in Vancouver

We are delighted to announce our participation in ASBMR 2023 Annual Meeting. The meeting will take place in Vancouver, Canada between October 13-16, 2023.

In our commitment to advancing the rare bone disease research, we will also be taking part in the Rare Bone Disease Symposium “From Molecules and Mechanisms to Therapeutics” on October 12, just one day before the official start of the ASBMR Annual Meeting.

Whether your research is focused on osteoporosis, osteoarthritis, cancer induced bone diseases, rare bone diseases or bone health studies, come and meet us at booth #218. To schedule a personal meeting, send us a message to info@pharmatest.com.

Here’s a sneak peek of what to expect from us at the event:

Poster Presentation SAT-196: Differences Between the Effects of Anti-Catabolic and Anabolic Treatments on Bone in Adult Ovariectomized Rats

Poster Presentation SAT-351: Human Osteoclast Assays for Identifying Antiresorptive Treatments with Different Mechanisms of Action

Our team is excited to share insights, research findings, and engage in discussions with fellow professionals, researchers, and experts in the field of bone and mineral research.

Stay tuned for updates from the event, and feel free to connect with us to learn more about our research capabilities.